Form 4: Forte Biosciences CEO Paul Wagner Reports Stock Transactions
SEC Form 4 Filing
Paul A. Wagner, CEO of Forte Biosciences, reports the vesting and disposal of restricted stock units and common stock transactions.
Summary
- On October 1, 2024, Paul A. Wagner, CEO of Forte Biosciences, reported transactions involving common stock and restricted stock units (RSUs).
- Wagner acquired 1,250 shares of common stock through the vesting of RSUs at a price of $0.
- Simultaneously, Wagner disposed of 98 shares of common stock at a price of $5.16.
- Following these transactions, Wagner directly owns 77,470 shares of Forte Biosciences common stock.
- The reported number of securities has been adjusted to reflect the Issuer's 1-for-25 reverse stock split effected on August 28, 2024.
- Wagner also holds 11,250 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an insider, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting insider transactions, providing transparency to investors regarding the buying and selling activities of company executives and directors.
Stakeholder Impact
- The transactions may provide insights to shareholders regarding management's perspective on the company's stock value.
Key Dates
| Date | Description |
|---|---|
| February 1, 2023 | First Quarterly Vesting Date for RSUs. |
| August 28, 2024 | Forte Biosciences effected a 1-for-25 reverse stock split. |
| October 1, 2024 | Date of reported stock transactions (RSU vesting and stock disposal). |
| October 2, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.